(Q45399754)

English

A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.

scientific article published on 11 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

vector-borne disease

0 references

Semliki Forest virus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Hidde J. Haisma

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

8

object named as

Wilschut J

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Riezebos-Brilman A

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Walczak M

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Regts J

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rots MG

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kamps G

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Dontje B

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Daemen T

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

11 October 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1695-1704

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.gt.3303036

0 references

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Induction of human papilloma virus E6/E7-specific cytotoxic T-lymphocyte activity in immune-tolerant, E6/E7-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

The papillomavirus life cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Human papillomavirus immortalization and transformation functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Gene therapy progress and prospects: adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Cell specificity and efficiency of the Semliki forest virus vector- and adenovirus vector-mediated gene expression in mouse cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-Expressing sindbis virus replicon particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Understanding the generation and function of memory T cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Generation and maintenance of immunological memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

21 January 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

7 January 2021

based on heuristic

inferred from DOI database lookup

The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

7 January 2021

based on heuristic

inferred from DOI database lookup

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303036

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3303036

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17928874%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45399754&oldid=2043406201"